Mortality and Lung Function Decline of Idiopathic Pulmonary Fibrosis Patient with Ezetimibe and Pirfenidone

被引:0
|
作者
Cho, Jinhyung [1 ]
Lee, Chanho [1 ]
Kwak, Se Hyun [1 ]
Kim, Young Sam [1 ]
机构
[1] Yonsei Univ, Med Coll, Seoul, South Korea
关键词
D O I
10.1183/13993003.congress-2023.PA1720
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] A Disease Progression Model of Longitudinal Lung Function Decline in Idiopathic Pulmonary Lung Fibrosis Patients
    Bi, Youwei
    Paterniti, Miya O.
    Karimi-Shah, Banu A.
    Chowdhury, Badrul A.
    Wang, Yaning
    Rekic, Dinko
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S47 - S48
  • [42] Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
    Lee, Eung Gu
    Lee, Tae-Hee
    Hong, Yujin
    Ryoo, Jiwon
    Heo, Jung Won
    Kang, Hye Seon
    Kwon, Soon Seog
    Kim, Yong Hyun
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [43] Progressive Effect of Pirfenidone on Lung Function in Patients with Idiopathic Pulmonary Fibrosis During the First Year of Treatment
    Llapur, C. J.
    Tabaj, G. C.
    Enghelmayer, J. I.
    Bosio, M. F.
    Alchapar, R. A.
    Victorio, C. F.
    Quadrelli, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [44] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [45] Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis
    Sridhar, Meenakshi
    Bodduluri, Sandeep
    O'Hare, Lanier
    Blumhoff, Scott
    Acosta Lara, Maria del Pilar
    de Andrade, Joao A.
    Kim, Young-Il
    Luckhardt, Tracy
    McDonald, Merrylynn
    Kulkarni, Tejaswini
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [46] Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis (IPF)
    Oldham, Justin M.
    Neely, Megan L.
    Wojdyla, Daniel
    Gulati, Mridu
    Li, Peide
    Patel, Divya
    Palmer, Scott M.
    Todd, Jamie L.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [47] Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis
    Meenakshi Sridhar
    Sandeep Bodduluri
    Lanier O’Hare
    Scott Blumhoff
    Maria del Pilar Acosta Lara
    Joao A. de Andrade
    Young-Il Kim
    Tracy Luckhardt
    MerryLynn McDonald
    Tejaswini Kulkarni
    Respiratory Research, 25
  • [48] A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patients
    Bi, Youwei
    Rekic, Dinko
    Paterniti, Miya O.
    Chen, Jianmeng
    Marathe, Anshu
    Chowdhury, Badrul A.
    Karimi-Shah, Banu A.
    Wang, Yaning
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2021, 48 (01) : 55 - 67
  • [49] A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patients
    Youwei Bi
    Dinko Rekić
    Miya O. Paterniti
    Jianmeng Chen
    Anshu Marathe
    Badrul A. Chowdhury
    Banu A. Karimi-Shah
    Yaning Wang
    Journal of Pharmacokinetics and Pharmacodynamics, 2021, 48 : 55 - 67
  • [50] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398